Impact of immature platelets and erythrocytes on clinical risk stratification of patients with atrial fibrilatio
- Conditions
- I48Atrial fibrillation and flutter
- Registration Number
- DRKS00023100
- Lead Sponsor
- niversitätsherzzentrum Bad Krozingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1632
Inclusion Criteria
men and women of at least 18 years of age with proven diagnosis of atrial fibrillation (at least one ECG document) with or without the indication for oral anticoagulation
Exclusion Criteria
missing laboratory parameters (IP, RetHe), people working for the institution, people with severe psychiatric disease or other desease making it impossible to collect valid answers after 12 month
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinically relevant bleeding complications (defined as BARC =2) or ischemic events after 12 month
- Secondary Outcome Measures
Name Time Method death of any cause, non-fatal myocardial infarction